Skip to main content
Go to the home page of the European Commission (opens in new window)
English English
CORDIS - EU research results
CORDIS
Content archived on 2022-12-23

Enantioselective synthesis of biologically important natural products and their analogues having anti-tumour, immunosuppressant as well as HMG-CoA reductase inhibitory activity

Objective



The goal of this project is the enantio and stereoselective synthesis of biologically important natural products and their analogues exhibiting anti-tumour and immunosuppressant properties as well as potential inhibitors of HMG-CoA reductase.

The research will be carried out as follows: total synthesis of Quadrone exhibiting anti-tumor properties; synthesis of the potent immonosuppressant Myrioan and analogues; and synthesis of HMG-CoA reductase inhibitor COMPACTIN.

Programme(s)

Multi-annual funding programmes that define the EU’s priorities for research and innovation.

Topic(s)

Calls for proposals are divided into topics. A topic defines a specific subject or area for which applicants can submit proposals. The description of a topic comprises its specific scope and the expected impact of the funded project.

Call for proposal

Procedure for inviting applicants to submit project proposals, with the aim of receiving EU funding.

Data not available

Funding Scheme

Funding scheme (or “Type of Action”) inside a programme with common features. It specifies: the scope of what is funded; the reimbursement rate; specific evaluation criteria to qualify for funding; and the use of simplified forms of costs like lump sums.

Data not available

Coordinator

Centre National de la Recherche Scientifique
EU contribution
No data
Address
Avenue de la Terrasse 1
91198 Gif-sur-Yvette
France

See on map

Total cost

The total costs incurred by this organisation to participate in the project, including direct and indirect costs. This amount is a subset of the overall project budget.

No data

Participants (4)

My booklet 0 0